Spondyloarthropathies News

The prevalence of ankylosing spondylitis more than doubled, from 0.04% to 0.09%, from 2006 to 2016, according to data published in BMC Rheumatology.

Inflammatory arthritis caused by immune checkpoint inhibitor therapy can develop into a long-term condition even after treatment cessation, requiring immunomodulatory intervention, according to findings published in Annals of the Rheumatic Diseases.

Continuous use of NSAIDs for the treatment of ankylosing spondylitis is associated with a 12% increased risk for incident hypertension, compared to non-continuous or no NSAID use, according to data published in Arthritis Care & Research.

Although cannabidiol — better known as CBD — may help patients with arthritis alleviate their pain, insomnia and anxiety, there have been no rigorous clinical studies to confirm these effects, and the product should never be used to replace DMARDs that prevent permanent joint damage, according to guidance from the Arthritis Foundation.

By the time Lilly Stairs was diagnosed with psoriatic arthritis at the age of 19 — following an arduous series of tests and doctor visits — she had already been living with an autoimmune disease for 12 years.

IBI303, a biosimilar to adalimumab developed by Chinese biopharmaceutical company Innovent Biologics, is comparable in safety and efficacy to the originator drug among patients with ankylosing spondylitis, according to data published in The Lancet Rheumatology.

Newly diagnosed patients with ankylosing spondylitis in Taiwan demonstrate increased risks for multiple immune-mediated inflammatory diseases, including acute anterior uveitis, psoriasis, thromboangiitis obliterans, Behcet’s disease and sarcoidosis, according to findings published in Arthritis Research & Therapy.

Among patients with axial spondyloarthritis receiving their first TNF inhibitor, 27% achieve inactive disease, defined by the Ankylosing Spondylitis Disease Activity Score, after 6 months, with approximately 80% continuing treatment after 1 year, according to data published in Annals of the Rheumatic Diseases.

Rheumatologists are generally familiar with complicated case patients who require management across specialties. The same goes for gastroenterologists. But a little more communication never hurts. In this case, a closer look at patients with inflammatory bowel disease-associated arthritis — known commonly as enteropathic arthritis — may be beneficial.

Alcohol consumption is significantly associated with spinal structural progression in patients with axial spondyloarthritis, according to data published in Arthritis Research & Therapy.